Table 8.
Results from dose plan analysis for Patient 4
| Obj | Corvus1 | Eclipse1 | Hyperion2 | KonRad1 | OMP2 | PinnEUD2 | PinnPhy2 | Precise2 | |
| PTV1 (18 Gy) | |||||||||
| Maxpt Gy | Prescript | 21.0 | 20.0 | 21.4 | 22.5 | 21.7 | 23.9 | 21.0 | 23.6 |
| D1% Gy | Prescript | 20.0 | 19.5 | 20.4 | 21.6 | 19.8 | 21.7 | 19.6 | 21.4 |
| D99% Gy | Prescript | 15.2 | 14.2 | 11.8 | 12.9 | 16.2 | 14.5 | 16.2 | 14.3 |
| V90% % | 100% | 96.8 | 96.7 | 91.9 | 95.2 | 99.0 | 97.4 | 99.0 | 97.6 |
| V107% % | 0% | 7.3 | 2.4 | 14.6 | 18.5 | 3.8 | 13.8 | 2.2 | 12.7 |
| SD Gy | 0 Gy | 0.9 | 0.9 | 1.5 | 1.5 | 0.7 | 1.2 | 0.6 | 1.2 |
| CI | 1.0 | 1.53 | 1.12 | 1.11 | 1.30 | 1.28 | 1.16 | 1.27 | 1.31 |
| Kidney | |||||||||
| Mean Gy | < 10 Gy | 7.7 | 5.1 | 6.4 | 8.0 | 9.3 | 7.7 | 9.7 | 9.3 |
| Max pt Gy | Minimise | 17.5 | 13.4 | 12.2 | 13.4 | 18.1 | 13.7 | 17.3 | 14.1 |
| D1% Gy | Minimise | 14.8 | 12.0 | 11.3 | 12.5 | 16.7 | 12.7 | 16.0 | 13.4 |
| V5 Gy % | Minimise | 78.6 | 39.7 | 72.2 | 97.2 | 98.0 | 87.8 | 97.3 | 98.1 |
| Healthy tissue | |||||||||
| Mean Gy | Minimise | 8.8 | 6.1 | 7.0 | 7.9 | 8.2 | 7.1 | 7.6 | 7.0 |
| Max pt Gy | Minimise | 20.5 | 19.7 | 17.7 | 22.6 | 21.6 | 20.6 | 20.6 | 23.1 |
| V10 Gy cm3 | Minimise | 1920 | 970 | 1200 | 1580 | 1650 | 1380 | 1600 | 1300 |
| nV10 Gy | Minimise | 1.9 | 0.8 | 0.9 | 1.3 | 1.4 | 1.1 | 1.3 | 1.1 |
| V90% cm3 | Minimise | 561 | 206 | 219 | 440 | 339 | 227 | 331 | 348 |
1: TPS belonging to the first family type
2: TPS belonging to the second family type